<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Interactive Pharmacology Roadmap</title>
    <style>
        body {
            font-family: 'Arial', sans-serif;
            line-height: 1.6;
            color: #333;
            max-width: 1000px;
            margin: 0 auto;
            padding: 20px;
            /* background-color: #fcf5f5; */
            background: linear-gradient(135deg, #ffebee 0%, #e53935 100%);
        }
        header {
            background: linear-gradient(135deg, var(--primary), var(--dark));
            color: white;
            padding: 1rem 0;
            width: 100%;
            box-shadow: 0 4px 12px rgba(0, 0, 0, 0.5);
        }
        .logo h1 {
            font-weight: 700;
            font-size: 2rem;
        }

        .logo {
            display: flex;
            align-items: center;
            justify-content: center;
            margin-bottom: 1rem;
        }
        
        .logo i {
            font-size: 2.5rem;
            margin-right: 1rem;
            color: var(--accent);
        }

        .btn {
            display: inline-block;
            background-color: var(--accent);
            color: white;
            padding: 1rem 2rem;
            border-radius: 4px;
            text-decoration: none;
            font-weight: 600;
            transition: all 0.3s ease;
            border: none;
            cursor: pointer;
            font-size: 1.1rem;
        }
        
        .btn:hover {
            background-color: #aa0000;
            transform: translateY(-2px);
            box-shadow: 0 4px 12px rgba(0, 0, 0, 0.2);
        }
        
        .btn i {
            margin-right: 0.8rem;
        }
        h1 {
            color: #b71c1c;
            border-bottom: 2px solid #e53935;   
            text-align: center;
            padding-bottom: 10px;
        }
        .roadmap {
            position: relative;
            background-color: white;
            border-radius: 10px;
            padding: 20px;
            margin: 20px 0;
            box-shadow: 0 3px 10px rgba(0,0,0,0.1);
            /* add space for the vertical line */
            padding-left: 40px;
        }   

        .roadmap::before {
            content: "";
            position: absolute;
            top: 30px;
            left: 20px;
            width: 4px;
            height: calc(100% - 60px);
            background: #e53935;
            border-radius: 2px;
            z-index: 0;
        }
        .topic {
            position: relative;
            margin: 30px 0;
            cursor: pointer;
            padding: 10px 10px 10px 30px;
            border-radius: 5px;
            background-color: #f8eaea;
            transition: all 0.3s ease;
            z-index: 1;
        }

        .topic::before {
        content: "";
        position: absolute;
        top: 24px;
        left: -30px;
        width: 30px;
        height: 4px;
        background: #e53935;
        border-radius: 2px;
        z-index: 1;
    }
    .topic:first-child {
        margin-top: 0;
    }
    .topic:last-child {
        margin-bottom: 0;
    }
        .topic:hover {
            background-color: #f1d7d4;
        }
        .topic h2 {
            color: #b71c1c;
            margin: 0;
            display: flex;
            justify-content: space-between;
            align-items: center;
        }
        .topic h2::after {
            content: "+";
            font-size: 1.5em;
        }
        .topic.active h2::after {
            content: "-";
        }
        .notes {
            display: none;
            padding: 15px;
            background-color: #f8f9fa;
            border-radius: 5px;
            margin-top: 10px;
            border-left: 4px solid #e53935;
        }
        .topic.active .notes {
            display: block;
        }
        .drug-name {
            font-weight: bold;
            color: #d32f2f;
        }
        .mechanism {
            font-style: italic;
            color: #27ae60;
        }
        .side-effects {
            background-color: #f8d7da;
            padding: 10px;
            border-radius: 5px;
            margin: 10px 0;
        }
        .key-point {
            background-color: #edd4d4;
            padding: 10px;
            border-radius: 5px;
            margin: 10px 0;
        }
        @media (max-width: 600px) {
            body {
                padding: 10px;
            }
            .roadmap {
                padding-left: 20px;
            }
            .roadmap::before {
                left: 10px;
                width: 2px;
            }
            .topic {
                padding-left: 18px;
            }
            .topic::before {
                left: -18px;
                width: 18px;
                height: 2px;
            }
            header .container {
                flex-direction: column;
                align-items: stretch;
                gap: 1rem;
            }

            header .container > div:first-child {
                display: flex;
                justify-content: center;
                gap: 1rem;
                margin-bottom: 0.5rem;
            }

            .logo {
                justify-content: center;
                margin-bottom: 0;
            }
        }
    </style>
</head>
<body>
    <header>
        <div class="container" style="display: flex; align-items: center; justify-content: space-between;">
            <div class="logo">
                <i class="fas fa-heartbeat"></i>
                <h1>ToToZ Collection</h1>
            </div>
            
            <div>
                <button onclick="window.location.href='index.html'" class="btn" style="margin-right: 1rem;">
                    <i class="fas fa-arrow-left"></i> Back
                </button>
                <a href="index.html" class="btn">
                    <i class="fas fa-home"></i> Home
                </a>
            </div>
            
        </div>
    </header>
    
    <h1>Heart Failure Management - Interactive Roadmap</h1>
    
    <div class="roadmap">
        <div class="topic">
            <h2>1. Sulphonamides</h2>
            <div class="notes">
                <p><span class="drug-name">Examples:</span> </p>
                <ol type="1">
                    <li>Nalidixic acid</li>
                    <li>Ciprofloxacin</li>
                    <li>Norfloxacin</li>
                    <li>Ofloxacin</li>
                    <li>Levofloxacin</li>
                    <li>Moxifloxacin</li>
                </ol>

                <p><span class="mechanism">Mechanism:</span> <br>
                    <ul style="list-style-type: square; padding-left: 20px;">
                        <li>Quinolones inhibit the two topoisomerases, DNA gyrase and topoisomerase IV.</li>
                        <li>Generally, DNA gyrase is the target of quinolones in gram-negative bacteria, while topoisomerase IV is the primary target in gram-positive organisms.</il>
                    </ul>
                </p>

                <p><strong>Indications:</strong></p>
                <ul>
                    <li><strong>Ciprofloxacin:</strong>
                        <ul>
                            <li>Effective against gram-negative bacteria like enteric gram-negative bacilli, gonococci, chlamydia, Pseudomonas aeruginosa. 
                            <li>Used to treat infections like UTI, prostatitis, and PID.</li>
                        </ul> 
                    </li>

                    <li><strong>Fluoroquinolones:</strong> 
                        <ul>
                            <li>Treat diarrhea infections caused by Campylobacter, Salmonella, Shigella, Yersinia enterocolitica</li>
                            <li>Effective against traveler's diarrhea caused by enterotoxigenic E. coli</li>
                            <li>Used with other drugs to treat intra-abdominal, bone, and skin infections</li>
                            <li>Advanced respiratory fluoroquinolones like levofloxacin, moxifloxacin, gemifloxacin are effective against pneumococci and used in respiratory tract infections (sinusitis, bronchitis, H. influenzae, M. catarrhalis)</li>
                            <li>Effective against community-acquired pneumonia</li>
                            <li>Used in mycobacterial infections including intracellular and multidrug-resistant tuberculosis</li>
                        </ul>
                    </li>
                </ul>

                <p><strong>Side Effects:</strong></p>
                <ul>
                    <li>Tendinitis and tendon rupture; avoid in children, adolescents, pregnant or nursing women</li>
                    <li>Increased risk of tendon rupture in elderly (>60 years), corticosteroid users, and those with kidney/heart/lung transplants</li>
                    <li>Prolongs QT interval (risk of arrhythmias)</li>
                    <li>Blood sugar alterations (hypoglycemia or hyperglycemia)</li>
                    <li>Seizures</li>
                    <li>Phototoxicity (dermatitis after exposure)</li>
                    <li>Inhibit cytochrome P450 1A2 (affects metabolism of drugs like caffeine, theophylline, etc.)</li>
                </ul>
                <div style="margin-top: 16px; background: #ffebee; border: 2px solid #e53935; border-radius: 8px; padding: 12px;">
                    <label for="audio-notes">
                        <i class="fas fa-volume-up" style="color: #e53935; margin-right: 6px;"></i>
                        <strong style="color: #b71c1c;">Listen to Audio Notes:</strong>
                    </label><br>
                    <audio id="audio-notes" controls style="width: 100%;">
                        <source src="audio/Hey Toto, do yo (1).mp3" type="audio/mpeg">
                        Your browser does not support the audio element.
                    </audio>
                </div>
            </div>
        </div>
        
        <div class="topic">
            <h2>2. Beta Blockers</h2>
            <div class="notes">
                <p><span class="drug-name">Examples:</span> Carvedilol, Bisoprolol, Metoprolol succinate</p>
                <p><span class="mechanism">Mechanism:</span> Block β1-adrenergic receptors → reduce sympathetic overactivity</p>
                <div class="key-point">
                    <strong>Important:</strong> Start at low dose and titrate slowly in stable patients
                </div>
                <p><strong>Key Points:</strong></p>
                <ul>
                    <li>Only use evidence-based beta blockers in HF</li>
                    <li>May initially worsen symptoms before improvement</li>
                    <li>Contraindicated in acute decompensated HF</li>
                </ul>
            </div>
        </div>
        
        <div class="topic">
            <h2>3. Mineralocorticoid Receptor Antagonists</h2>
            <div class="notes">
                <p><span class="drug-name">Examples:</span> Spironolactone, Eplerenone</p>
                <p><span class="mechanism">Mechanism:</span> Block aldosterone effects → reduce sodium retention and fibrosis</p>
                <div class="side-effects">
                    <strong>Monitoring Required:</strong> Potassium levels (risk of hyperkalemia), renal function
                </div>
                <p><strong>Clinical Use:</strong></p>
                <ul>
                    <li>NYHA Class II-IV with reduced EF</li>
                    <li>Post-MI with reduced EF and symptoms</li>
                </ul>
            </div>
        </div>
        
        <div class="topic">
            <h2>4. ARNI (Sacubitril/Valsartan)</h2>
            <div class="notes">
                <p><span class="drug-name">Brand Name:</span> Entresto</p>
                <p><span class="mechanism">Dual Mechanism:</span></p>
                <ul>
                    <li>Sacubitril: Inhibits neprilysin → ↑ natriuretic peptides</li>
                    <li>Valsartan: ARB effects</li>
                </ul>
                <div class="key-point">
                    <strong>PARADIGM-HF Trial:</strong> Showed superiority over enalapril in reducing CV death and HF hospitalization
                </div>
                <p><strong>Switching Protocol:</strong></p>
                <ol>
                    <li>Stop ACE inhibitor</li>
                    <li>36-hour washout period</li>
                    <li>Start ARNI at low dose</li>
                </ol>
            </div>
        </div>
        
        <div class="topic">
            <h2>5. Diuretics</h2>
            <div class="notes">
                <p><span class="drug-name">Loop Diuretics:</span> Furosemide, Bumetanide, Torsemide</p>
                <p><span class="drug-name">Thiazides:</span> Hydrochlorothiazide, Chlorthalidone (for mild HF)</p>
                <p><strong>Clinical Use:</strong></p>
                <ul>
                    <li>Symptom relief (no mortality benefit)</li>
                    <li>Adjust dose to maintain euvolemia</li>
                    <li>Combine with salt restriction</li>
                </ul>
                <div class="side-effects">
                    <strong>Adverse Effects:</strong> Electrolyte disturbances, dehydration, ototoxicity (loops), gout, photosensitivity (thiazides)
                </div>
            </div>
        </div>
        
        <div class="topic">
            <h2>6. SGLT2 Inhibitors</h2>
            <div class="notes">
                <p><span class="drug-name">Examples:</span> Dapagliflozin, Empagliflozin</p>
                <p><span class="mechanism">Mechanism:</span> Inhibit renal glucose reabsorption → osmotic diuresis, may improve myocardial metabolism</p>
                <p><strong>Key Trials:</strong></p>
                <ul>
                    <li>DAPA-HF: Dapagliflozin in HFrEF</li>
                    <li>EMPEROR-Reduced: Empagliflozin in HFrEF</li>
                    <li>EMPEROR-Preserved: Empagliflozin in HFpEF</li>
                </ul>
                <div class="key-point">
                    <strong>Advantage:</strong> Benefits seen regardless of diabetes status
                </div>
            </div>
        </div>
        
        <div class="topic">
            <h2>7. Additional Therapies</h2>
            <div class="notes">
                <p><span class="drug-name">Digoxin:</span> Symptom relief in sinus rhythm, no mortality benefit</p>
                <p><span class="drug-name">Ivabradine:</span> For patients with HR >70 on max BB dose</p>
                <p><span class="drug-name">Hydralazine/ISDN:</span> Especially beneficial in African Americans</p>
                <p><strong>Device Therapy:</strong></p>
                <ul>
                    <li>ICD for primary/secondary prevention</li>
                    <li>CRT for specific QRS patterns</li>
                </ul>
            </div>
        </div>
    </div>

    <script>
        // JavaScript to handle the click events
        document.querySelectorAll('.topic h2').forEach(header => {
            header.addEventListener('click', function() {
                const topic = this.parentElement;
                topic.classList.toggle('active');
                
                // Close other open topics (optional)
                document.querySelectorAll('.topic').forEach(otherTopic => {
                    if (otherTopic !== topic && otherTopic.classList.contains('active')) {
                        otherTopic.classList.remove('active');
                    }
                });
            });
        });
    </script>
</body>
</html>